Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3902-3904

  Gimm, Oliver ^a   Marsh, Debbie J ^a   Andrew, Scott D ^b   Frilling, Andrea ^c   Dahia, Patricia L M ^a   Mulligan, Lois M ^d   Zajac, Jeffrey D ^e   Robinson, Bruce G ^b   Eng, Charis ^a,f,g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF HAMBURG   (Germany)

^d QUEEN S UNIVERSITY   (Canada)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CODON; EXON; GENE MUTATION; GENETIC POLYMORPHISM; GERM LINE; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0030722592     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.11.4508     Document Type: Article

References (22)

1. Schimke RN. 1984 Genetic aspects of multiple endocrine neoplasia. Annu Rev Med 35:25-31.
2. Schimke RN, Hartmann WH, Prout TW, Rimoin DL. 1968 Syndrome of bilateral pheochromoctyoma, medullary thyroid carcinoma and multiple neuromas. N Engl J Med 279:1-7.
3. Gorlin RJ, Sedano HO, Vickers RA, Cervenka J. 1968 Multiple mucosal neuromas, phaeochromocytoma and medullary carcinoma of the thyroid - a syndrome. Cancer 22:293-299.
4. Eng C. 1996 The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung disease. N Engl J Med 335:943-951.
5. Eng C, Clayton D, Schuffenecker I, et al. 1996 The relationship between specific RET protooncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis. JAMA 276:1575-1579.
6. Mulligan LM, Marsh DJ, Robinson BG, et al. 1995 Genotype-phenotype correlation in MEN 2: Report of the International RET Mutation Consortium. J Intern Med 238:343-346.
7. Eng C, Mulligan LM. 1997 Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2, related sporadic tumours and Hirschsprung diseaes. Hum Mutat 9:97-109.
8. Toogood AA, Eng C, Smith DP, Ponder BAJ, Shalet SM. 1995 No mutation at codon 918 of the RET gene in a family with multiple endocrine neoplasia type 2B. Clin Endocrinol 43:759-762.
9. Ponder BAJ, Smith DP, Reynolds LF, et al. 1997 Clinical and molecular genetics of MEN 2: an overview. Sixth Intl Wrkshp MEN and VHL Abstract 109:50.
10. Mathew CGP, Smith BA, Thorp K, et al. 1987 Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328:524-526.
11. Mulligan LM, Eng C, Attié T, et al. 1994 Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 3:2163-2167.
12. Liaw D, Marsh DJ, Li J, et al. 1997 Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet 16:64-67.
13. Marsh DJ, Dahia PLM, Coulon V, et al. 1997 Allelic imbalance, including deletion of PTENIMMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chrom Cancer, in press
14. Takahashi M, Cooper GM. 1987 R E T transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 3:1378-1385.
15. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H. 1988 Cloning and expression of the ret proto-oncogene encoding a receptor tyrosine kinase with two potential transmembrane domains. Oncogene 3:571-578.
16. Eng C, Smith DP, Mulligan LM, et al. 1995 A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10:509-513.
17. Bolino A, Schuffenecker I, Luo Y, et al. 1995 RET mutations in exons 13 and 14 of FMTC patients. Oncogene 10:2415-2419.
18. Eng C, Mulligan LM, Healey CS, et al. 1996 Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res 56:2167-2170.
19. Hanks SK, Quinn AM, Hunter T. 1988 The protein kinase family: conserved features and deduced phylogeny of the catalytic domain. Science 241:42-52.
20. Songyang Z, Carraway III KL, Eck MJ, et al. 1995 Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-539.
21. Borrello MG, Smith DP, Pasini B, et al. 1995 RET activation by germline MEN2A and MEN2B mutations. Oncogene 11:2419-2427.
22. Santoro M, Carlomagno F, Romano A, et al. 1995 Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267:381-383.